Type 2 diabetes (or diabetes mellitus) is a common metabolic and vascular disorder that is defined by chronic hyperglycemia and mostly dyslipidemia and hypertension in obese people. In 75% of the cases, the patients are multimorbid and these disorders occurred together as a metabolic vascular syndrome. The prevalence of type 2 diabetes is increasing rapidly, driven by the increasing epidemic of obesity. It is believed that there will be as many as 300 million people with diabetes worldwide by the year 2025. Most of the increase will occur in developing countries.

Despite the introduction of multiple new classes of antidiabetic agents for the treatment of type 2 diabetes, and newer insulin preparation, glycaemic control is suboptimal in approximately half of all diabetic patients. In addition, patients with diabetes, especially those with long-standing diabetes, may develop complications affecting the eyes, kidneys, or nerves (microvascular complications) or major arteries (macrovascular complications).

The aim of this Special Issue is to focus on a more holistic approach to patient management, keeping with the multiple metabolic effects of diabetes. We invite you to submit original research articles highlighting updates on the management of type 2 diabetes. State-of-the-art review articles are also welcome.

Potential topics include but are not limited to the following:

• Recommended diets to manage type 2 diabetes
• Recommended exercises to manage type 2 diabetes
• Current and novel drugs for the treatment of diabetes mellitus
• Management of type 2 diabetes in obese adolescents
• Obesity, dyslipidaemia, hypertension in type 2 diabetes
• Basic principles and clinical data of type 2 diabetes complications
• Patient management with metabolic vascular syndrome